Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

<p>Abstract</p> <p>Background</p> <p>As a member of the TNF superfamily, TRAIL could induce human tumor cell apoptosis through its cognate death receptors DR4 or DR5, which can induce formation of the death inducing signaling complex (DISC) and activation of the membran...

Bibliografske podrobnosti
Main Authors:	Qiao Chunxia, Hu Meiyun, Guo Leiming, Lv Ming, Lin Zhou, Geng Jing, Lang Xiaoling, Li Xinying, Li Yan, Ma Yuanfang, Feng Jiannan, Shen Beifen
Format:	Article
Jezik:	English
Izdano:	BMC 2012-07-01
Serija:	BMC Immunology
Teme:	TRAIL Death receptor 5 Monoclonal antibody Apoptosis Breast cancer
Online dostop:	http://www.biomedcentral.com/1471-2172/13/40

Podobne knjige/članki

Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia
od: Min Cui, et al.
Izdano: (2010-08-01)

Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury
od: Danyang Zhao, et al.
Izdano: (2023-05-01)

Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling
od: Xiao Tian, et al.
Izdano: (2024-02-01)

Macrophage-like THP-1 Cells Derived from High-Density Cell Culture Are Resistant to TRAIL-Induced Cell Death via Down-Regulation of Death-Receptors DR4 and DR5
od: Yana Vladimirovna Lomovskaya, et al.
Izdano: (2022-01-01)

Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo
od: Xinran Qiao, et al.
Izdano: (2018-07-01)

Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
od: Agathe Dubuisson, et al.
Izdano: (2017-10-01)

Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression
od: Seok Kim, et al.
Izdano: (2018-07-01)

CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide
od: Jayaprakasam Madhumathi, et al.
Izdano: (2017-03-01)

Targeting Death Receptor 5 (DR5) for the imaging and treatment of primary bone and soft tissue tumors: an update of the literature
od: Zakareya Gamie, et al.
Izdano: (2024-09-01)

Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells
od: Seon Min Woo, et al.
Izdano: (2020-10-01)

Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells
od: Jeong Mi Yun, et al.
Izdano: (2018-09-01)

Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5
od: Juan LI, et al.
Izdano: (2017-02-01)

Maritoclax Enhances TRAIL-Induced Apoptosis via CHOP-Mediated Upregulation of DR5 and miR-708-Mediated Downregulation of cFLIP
od: Mi-Yeon Jeon, et al.
Izdano: (2018-11-01)

NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
od: Taiga Seki, et al.
Izdano: (2021-11-01)

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5
od: de Vries Elisabeth GE, et al.
Izdano: (2011-01-01)

Amphiphilic Poly(<i>N</i>-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells
od: Anne Yagolovich, et al.
Izdano: (2021-09-01)

Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
od: Catrin Heim, et al.
Izdano: (2024-06-01)

DR5‐Cbl‐b/c‐Cbl‐TRAF2 complex inhibits TRAIL‐induced apoptosis by promoting TRAF2‐mediated polyubiquitination of caspase‐8 in gastric cancer cells
od: Ling Xu, et al.
Izdano: (2017-12-01)

Landscape space 5 : walking space
Izdano: ([200)

Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4
od: Ismael Obaidi, et al.
Izdano: (2020-05-01)

First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer
od: Feng Wang, et al.
Izdano: (2021-07-01)

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile
od: Anne V. Yagolovich, et al.
Izdano: (2020-04-01)

Urban trails : a preliminary list of trails and sources/
od: 409605 Goodey, Brian
Izdano: (1974)

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.
od: Mongkolsapaya, J, et al.
Izdano: (1999)

The release of soluble forms of TRAIL and DR5 by neutrophils of oral cavity cancer patients.
od: Magdalena Marcinczyk, et al.
Izdano: (2008-06-01)

Combination of oridonin and TRAIL induces apoptosis in uveal melanoma cells by upregulating DR5
od: Xin Hua, et al.
Izdano: (2021-12-01)

Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
od: Khuri Fadlo R, et al.
Izdano: (2010-01-01)

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
od: Artem A. Artykov, et al.
Izdano: (2021-09-01)

Planning for urban trails/
od: 8697 American Society of Planning Officials, et al.
Izdano: (1969)

“Wild” Generosity: The Role of Trail Angels in Shaping Community on America’s Long-Distance Hiking Trails
od: Kristi McLeod
Izdano: (2024-07-01)

Corrigendum: Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
od: Artem A. Artykov, et al.
Izdano: (2022-02-01)

Selective targeting of DR5 circumvents resistance of MG-63 osteosarcoma to trail-induced apoptosis
od: Locklin, R, et al.
Izdano: (2006)

TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
od: Barbara Toffoli, et al.
Izdano: (2021-11-01)

‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle
od: Mohamad Mohty, et al.
Izdano: (2022-11-01)

Traals for the twenty-first century : planning, design, and managemant manual for multi use-trails /
od: Ryan, Karen-Lee
Izdano: (1993)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
od: RACHANA eTRIVEDI, et al.
Izdano: (2015-04-01)

OBSERVATIONAL TRAILS IN LIPIDOLOGY
od: S. A. Shalnova
Izdano: (2016-01-01)

Long-lived meteor trails
od: Mikhalev A.V., et al.
Izdano: (2019-09-01)

TRAIL/DR5 signaling promotes macrophage foam cell formation by modulating scavenger receptor expression.
od: Fang Fang Liu, et al.
Izdano: (2014-01-01)

Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2
od: Dongjin Jeong, et al.
Izdano: (2021-07-01)